Endotronix Receives FDA Premarket Approval of the Cordella PA Sensor System for the Treatment of Heart Failure
DAIC
JUNE 24, 2024
Reimbursement for implantation and ongoing management through existing reimbursement pathways. "At At Endotronix, we firmly believe that innovation can drive patient care excellence in the home and ultimately change outcomes for patients with heart failure, one of the largest cost categories in healthcare. later this year.
109 
Let's personalize your content